GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Decision Diagnostics Corp (OTCPK:DECN) » Definitions » 3-Year FCF Growth Rate

Decision Diagnostics (Decision Diagnostics) 3-Year FCF Growth Rate

: 0.00% (As of Sep. 2021)
View and export this data going back to . Start your Free Trial

Decision Diagnostics's Free Cash Flow per Share for the three months ended in Sep. 2021 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Competitive Comparison

For the Pharmaceutical Retailers subindustry, Decision Diagnostics's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Decision Diagnostics 3-Year FCF Growth Rate Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Decision Diagnostics's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Decision Diagnostics's 3-Year FCF Growth Rate falls into.



Decision Diagnostics 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Decision Diagnostics  (OTCPK:DECN) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Decision Diagnostics 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Decision Diagnostics's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Decision Diagnostics (Decision Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
2660 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361
Decision Diagnostics Corp is a provider of prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and a developer of revolutionary, cell phone centric, e-health products and technology. The company also provides blood glucose home testing test strips and exciting new concepts for blood testing monitors.
Executives
Keith Berman director, officer: Secretary 2660 TOWNSGATE RD #300, WESTLAKE VILLAGE CA 91361
Robert Jagunich director 765 CHRISTINE DR PALO ALTO CA 94303
Robert Lawrence Cox director, officer: President

Decision Diagnostics (Decision Diagnostics) Headlines

From GuruFocus